Revelation Biosciences secures FDA acceptance for Gemini IND, Phase 1b CKD study set for 2025
Zai Lab and Novocure report positive Phase 3 results for TTFields in pancreatic cancer
Bruker unveils Dimension Nexus AFM at 2024 MRS Fall Meeting
MicuRx completes Phase III trial for MRX-4 for injection in China
Renalys Pharma secures Orphan Drug Designation in Japan for sparsentan
Minghui Pharmaceutical reports phase III success for MH004 ointment in atopic dermatitis
CBC Group acquires UCB's mature neurology and allergy business in China
MGI Tech collaborates with Universidad de San Martin de Porres
Allink Biotherapeutics completes USD42m Series A financing round
Galderma reports Phase III data for nemolizumab in prurigo nodularis published in JAMA Dermatology
Sichuan Kelun-Biotech's sacituzumab tirumotecan receives Chinese regulatory approval
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children
GSK secures EU approval for fully liquid Menveo vaccine
Oxford Nanopore and UK Biobank partner to create world's largest epigenetic dataset